Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nurix Therapeutics Inc
(NQ:
NRIX
)
21.19
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nurix Therapeutics Inc
< Previous
1
2
3
Next >
Analyst Ratings for Nurix Therapeutics
May 27, 2022
Within the last quarter, Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings:
Via
Benzinga
10 Biggest Price Target Changes For Friday
May 27, 2022
Keybanc boosted Broadcom Inc. (NASDAQ: AVGO) price target from $720 to $780. Broadcom shares rose 0.1% to $551.44 in pre-market trading.
Via
Benzinga
88 Biggest Movers From Yesterday
May 27, 2022
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 26, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
On Thursday, 94 companies set new 52-week lows.
Via
Benzinga
Nurix Therapeutics Doses First Patient in Phase 1a/1b Study of NX-5948 For B-cell malignancies
May 17, 2022
Nurix Therapeutics, Inc. (NASDAQ: NRIX) announced that the first patient has been dosed in the Phase 1a/1b study to evaluate orally available small molecule NX-5948, in patients with relapsed B-cell...
Via
Benzinga
Seagen CEO Clay Siegall Resigns After Domestic Violence Arrest
May 16, 2022
Clay Siegall and the board agreed it would be in investors' best interest if he resigned.
Via
Investor's Business Daily
61 Stocks Moving In Thursday's Mid-Day Session
May 26, 2022
Via
Benzinga
Nurix Therapeutics' BTK Programs Show Encouraging Preclinical Action In Blood Cancer, Solid Tumors
April 11, 2022
Nurix Therapeutics Inc (NASDAQ: NRIX) announced the
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 08, 2022
Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,...
Via
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Nurix Therapeutics: Q4 Earnings Insights
January 27, 2022
Nurix Therapeutics (NASDAQ:NRIX) reported its Q4 earnings results on Thursday, January 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
65 Biggest Movers From Yesterday
January 19, 2022
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...
Via
Benzinga
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
December 29, 2021
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current
Via
Talk Markets
60 Biggest Movers From Yesterday
January 11, 2022
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company...
Via
Benzinga
Why Nurix Therapeutics Stock Soared More Than 21% Wednesday
October 27, 2021
The clinical-stage biopharmaceutical company posted positive news regarding its lead therapy -- a BTK inhibitor that could fight certain blood-based cancers.
Via
The Motley Fool
64 Biggest Movers From Yesterday
October 28, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via
Benzinga
Why Did SVB Leerink Beef Up Target Price For Nurix Therapeutics?
October 27, 2021
SVB Leerink raised the price target on Nurix Therapeutics Inc (NASDAQ: NRIX) to $64 from $50, with an Outperform rating, seeing an upside of almost 92%. Analyst...
Via
Benzinga
Nurix Shares Gain On Encouraging Early Data From Blood Cancer Trial
October 27, 2021
Nurix Therapeutics Inc (NASDAQ: NRIX) announced initial data from Phase 1a trial of NX-2127 in relapsed or refractory B cell malignancies. Initial data from the...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:
Via
Benzinga
Return on Capital Employed Insights for Nurix Therapeutics
July 29, 2021
After pulling data from Benzinga Pro it seems like during Q2, Nurix Therapeutics (NASDAQ:NRIX) brought in sales totaling $7.09 million. However, earnings decreased 7.72%,...
Via
Benzinga
Return on Capital Employed Insights for Nurix Therapeutics
July 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Nurix Therapeutics (NASDAQ:NRIX) brought in sales totaling $7.09 million. However, earnings decreased 7.72%,...
Via
Benzinga
48 Biggest Movers From Yesterday
April 15, 2021
Gainers Alkami Technology, Inc. (NASDAQ: ALKT) shares surged 43.3% to settle at $43.00 on Wednesday after the company priced its IPO at $30 per share. Coinbase Global, Inc. (...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Mid-Afternoon Market Update: Dow Gains Over 100 Points; Bed Bath & Beyond Shares Plummet
April 14, 2021
Toward the end of trading Wednesday, the Dow traded up 0.33% to 33,787.64 while the NASDAQ fell 0.62% to 13,908.97. The S&P also fell, dropping 0.22% to 4,132.40. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
April 14, 2021
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.